Principal Financial Group Inc Anika Therapeutics, Inc. Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$25.16 - $28.86 $104,992 - $120,432	-4,173 Reduced 4.6%	86,585 $2.25 Million
Q1 2023 May 09, 2023	SELL	$25.91 - $32.1 $28,708 - $35,566	-1,108 Reduced 1.21%	90,758 $2.61 Million
Q4 2022 Feb 09, 2023	SELL	$23.85 - $31.91 $25,376 - $33,952	-1,064 Reduced 1.14%	91,866 $2.72 Million
Q3 2022 Nov 09, 2022	SELL	$21.74 - $24.68 $101,960 - $115,749	-4,690 Reduced 4.8%	92,930 $2.21 Million
Q2 2022 Aug 10, 2022	SELL	$20.4 - $25.53 $124,011 - $155,196	-6,079 Reduced 5.86%	97,620 $2.18 Million
Q1 2022 May 09, 2022	SELL	$24.7 - $36.54 $124,315 - $183,905	-5,033 Reduced 4.63%	103,699 $2.6 Million
Q4 2021 Feb 09, 2022	SELL	$35.83 - $45.03 $202,296 - $254,239	-5,646 Reduced 4.94%	108,732 $3.9 Million
Q3 2021 Nov 09, 2021	SELL	$38.75 - $44.47 $51,033 - $58,566	-1,317 Reduced 1.14%	114,378 $4.87 Million
Q2 2021 Aug 10, 2021	BUY	$39.42 - $48.08 $166,549 - $203,138	4,225 Added 3.79%	115,695 $5.01 Million
Q1 2021 May 10, 2021	BUY	$32.49 - $45.96 $54,648 - $77,304	1,682 Added 1.53%	111,470 $4.55 Million
Q4 2020 Feb 08, 2021	SELL	$32.59 - $45.26 $633,582 - $879,899	-19,441 Reduced 15.04%	109,788 $4.97 Million
Q3 2020 Nov 06, 2020	BUY	$32.56 - $38.57 $278,029 - $329,349	8,539 Added 7.08%	129,229 $4.57 Million
Q2 2020 Aug 05, 2020	BUY	$27.83 - $37.73 $158,575 - $214,985	5,698 Added 4.96%	120,690 $4.55 Million
Q1 2020 May 12, 2020	SELL	$22.38 - $54.06 $99,635 - $240,675	-4,452 Reduced 3.73%	114,992 $3.32 Million
Q4 2019 Feb 05, 2020	BUY	$51.85 - $73.36 $556,454 - $787,299	10,732 Added 9.87%	119,444 $6.19 Million
Q3 2019 Nov 13, 2019	SELL	$40.05 - $57.47 $209,501 - $300,625	-5,231 Reduced 4.59%	108,712 $5.97 Million
Q2 2019 Aug 12, 2019	SELL	$30.3 - $41.14 $7,696 - $10,449	-254 Reduced 0.22%	113,943 $4.63 Million
Q1 2019 May 10, 2019	SELL	$29.37 - $40.49 $34,597 - $47,697	-1,178 Reduced 1.02%	114,197 $3.45 Million
Q4 2018 Feb 14, 2019	SELL	$30.16 - $43.0 $202,252 - $288,358	-6,706 Reduced 5.49%	115,375 $3.88 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $42.51 $96,815 - $125,361	2,949 Added 2.48%	122,081 $5.15 Million
Q2 2018 Aug 13, 2018	BUY	$28.77 - $48.27 $44,507 - $74,673	1,547 Added 1.32%	119,132 $0
Q1 2018 May 14, 2018	BUY	$49.22 - $68.43 $166,166 - $231,019	3,376 Added 2.96%	117,585 $5.85 Million
Q4 2017 Feb 13, 2018	BUY	$52.14 - $59.94 $191,249 - $219,859	3,668 Added 3.32%	114,209 $6.16 Million
Q3 2017 Nov 02, 2017	BUY	$51.16 - $58.21 $5.66 Million - $6.43 Million	110,541	110,541 $6.41 Million

Others Institutions Holding ANIK

# of Institutions

123

Shares Held

11.5M

Call Options Held

200

Put Options Held

100

Trigran Investments, Inc.

2.12M
Shares

$34.4 Million
5.75% of portfolio
Black Rock Inc. New York, NY

1.61M
Shares

$26 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

799K
Shares

$12.9 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

707K
Shares

$11.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

574K
Shares

$9.3 Million
0.02% of portfolio

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $236M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account